Cargando…

Pharmacokinetics of preoperative intraperitoneal 5-FU in patients with pancreatic ductal adenocarcinoma

PURPOSE: The aim was to investigate the pharmacokinetics of preoperatively administered intraperitoneal (IP) 5-FU in patients with resectable pancreatic ductal adenocarcinoma (PDAC) by analyzing levels of 5-FU and target metabolites in peritoneal fluid, plasma, liver, lymph nodes, pancreatic tumour,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Öman, Mikael, Wettergren, Yvonne, Odin, Elisabeth, Westermark, Sofia, Naredi, Peter, Hemmingsson, Oskar, Taflin, Helena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8367903/ https://www.ncbi.nlm.nih.gov/pubmed/34132895 http://dx.doi.org/10.1007/s00280-021-04318-x

Ejemplares similares

Plasma deoxyuridine as a surrogate marker for toxicity and early clinical response in patients with metastatic colorectal cancer after 5-FU-based therapy in combination with arfolitixorin
por: Taflin, Helena, et al.
Publicado: (2020)

A pharmacokinetic and pharmacodynamic investigation of Modufolin(®) compared to Isovorin(®) after single dose intravenous administration to patients with colon cancer: a randomized study
por: Wettergren, Yvonne, et al.
Publicado: (2014)

Folate levels measured by LC–MS/MS in patients with colorectal cancer treated with different leucovorin dosages
por: Taflin, Helena, et al.
Publicado: (2014)

Increasing Dosage of Leucovorin Results in Pharmacokinetic and Gene Expression Differences When Administered as Two-Hour Infusion or Bolus Injection to Patients with Colon Cancer
por: Taflin, Helena, et al.
Publicado: (2022)

Folate Levels and Polymorphisms in the Genes MTHFR, MTR, and TS in Colorectal Cancer
por: Taflin, Helena, et al.
Publicado: (2014)

Relationship between folate concentration and expression of folate-associated genes in tissue and plasma after intraoperative administration of leucovorin in patients with colorectal cancer
por: Taflin, Helena, et al.
Publicado: (2018)

A Case of Pancreatic Ductal Adenocarcinoma Arising From Atypical Flat Lesions
por: Franklin, Oskar, et al.
Publicado: (2020)

Depletion of the ER chaperone ENPL-1 sensitizes C. elegans to the anticancer drug cisplatin
por: Natarajan, Balasubramanian, et al.
Publicado: (2013)

The Resection Rate of Synchronously Detected Liver and Lung Metastasis from Colorectal Cancer Is Low—A National Registry-Based Study
por: Engstrand, Jennie, et al.
Publicado: (2023)

Thymidine Phosphorylase Gene Expression in Stage III Colorectal Cancer
por: Lindskog, Elinor B., et al.
Publicado: (2012)

Intraperitoneal Paclitaxel Treatment for Patients with Pancreatic Ductal Adenocarcinoma with Peritoneal Dissemination Provides a Survival Benefit
por: Yamamoto, Tomohisa, et al.
Publicado: (2022)

EGFR, but not COX-2, protein in resected pancreatic ductal adenocarcinoma is associated with poor survival
por: Fagman, Johan Bourghardt, et al.
Publicado: (2019)

Efficacy and tolerance of LV5FU2-carboplatin chemotherapy in patients with advanced pancreatic ductal adenocarcinoma after failure of standard regimens
por: Chaigneau, Thomas, et al.
Publicado: (2023)

Radiomics nomogram for the preoperative prediction of lymph node metastasis in pancreatic ductal adenocarcinoma
por: Bian, Yun, et al.
Publicado: (2022)

Clinical Impact of Preoperative Biliary Drainage in Patients with Ductal Adenocarcinoma of the Pancreatic Head
por: Amaral, Maria João, et al.
Publicado: (2023)

Alternative redox forms of ASNA-1 separate insulin signaling from tail-anchored protein targeting and cisplatin resistance in C. elegans
por: Raj, Dorota, et al.
Publicado: (2021)

Reciprocal regulation of DGCR5 and miR-320a affects the cellular malignant phenotype and 5-FU response in pancreatic ductal adenocarcinoma
por: Yong, Sun, et al.
Publicado: (2017)

Preoperative evaluation of pancreatic ductal adenocarcinoma with synchronous liver metastasis: Diagnosis and assessment of unresectability
por: Shi, Hao-Jun, et al.
Publicado: (2016)

A Radiomics Nomogram for the Preoperative Prediction of Lymph Node Metastasis in Pancreatic Ductal Adenocarcinoma
por: Gao, Jiahao, et al.
Publicado: (2020)

Clinical importance of preoperative and postoperative prognostic nutritional index in patients with pancreatic ductal adenocarcinoma
por: Ikeguchi, Masahide, et al.
Publicado: (2019)

The Prognostic Value of Preoperative Geriatric Nutritional Risk Index in Patients with Pancreatic Ductal Adenocarcinoma
por: Hu, Si-Pin, et al.
Publicado: (2020)

Additive Value of Preoperative Sarcopenia and Lymphopenia for Prognosis Prediction in Localized Pancreatic Ductal Adenocarcinoma
por: d’Engremont, Christelle, et al.
Publicado: (2021)

A phase I and pharmacokinetic study of intraperitoneal topotecan
por: Hofstra, L S, et al.
Publicado: (2001)

Intraperitoneal pharmacokinetics of vancomycin in patients on automated peritoneal dialysis
por: Lam, Edwin, et al.
Publicado: (2021)

Clinical impact of preoperative endoscopic ultrasound-guided fine-needle aspiration for pancreatic ductal adenocarcinoma
por: Tsutsumi, Hideharu, et al.
Publicado: (2016)

Preoperative Imaging Evaluation after Downstaging of Pancreatic Ductal Adenocarcinoma: A Multi-Center Study
por: Beleù, Alessandro, et al.
Publicado: (2019)

Preoperative Biomarker Panel, Including Fibrinogen and FVIII, Improves Diagnostic Accuracy for Pancreatic Ductal Adenocarcinoma
por: Mattila, Nora, et al.
Publicado: (2018)

Pancreatic ductal adenocarcinoma and distal cholangiocarcinoma: a proposal of preoperative diagnostic score for differential diagnosis
por: Muttillo, Edoardo Maria, et al.
Publicado: (2021)

Benefits of Dual-Layer Spectral CT Imaging in Staging and Preoperative Evaluation of Pancreatic Ductal Adenocarcinoma
por: Ehrengut, Constantin, et al.
Publicado: (2023)

Preoperative assessment of peripheral vascular invasion of pancreatic ductal adenocarcinoma based on high-resolution MRI
por: Zhou, Xiaoqi, et al.
Publicado: (2023)

Dissecting cell-type-specific metabolism in pancreatic ductal adenocarcinoma
por: Lau, Allison N, et al.
Publicado: (2020)

Drug Repurposing Opportunities in Pancreatic Ductal Adenocarcinoma
por: Rebelo, Rita, et al.
Publicado: (2021)

An Automated Prognostic Model for Pancreatic Ductal Adenocarcinoma
por: Vezakis, Ioannis, et al.
Publicado: (2023)

Pharmacokinetics and pharmacodynamics of locoregional 5 fluorouracil (5FU) in advanced colorectal liver metastases.
por: Goldberg, J. A., et al.
Publicado: (1988)

Intraperitoneal clearance as a potential biomarker of cisplatin after intraperitoneal perioperative chemotherapy: a population pharmacokinetic study
por: Royer, B, et al.
Publicado: (2012)

Preoperative Serum CA125 Levels Predict the Prognosis in Hyperbilirubinemia Patients With Resectable Pancreatic Ductal Adenocarcinoma
por: Chen, Tao, et al.
Publicado: (2015)

Comparison and validation of the value of preoperative inflammation marker-based prognostic scores in resectable pancreatic ductal adenocarcinoma
por: Ye, Sisi, et al.
Publicado: (2018)

CTC phenotyping for a preoperative assessment of tumor metastasis and overall survival of pancreatic ductal adenocarcinoma patients
por: Sun, Yukun, et al.
Publicado: (2019)

Resectable pancreatic ductal adenocarcinoma: association between preoperative CT texture features and metastatic nodal involvement
por: Fang, Wei Huan, et al.
Publicado: (2020)

Preoperative Multiparametric Quantitative Magnetic Resonance Imaging Correlates with Prognosis and Recurrence Patterns in Pancreatic Ductal Adenocarcinoma
por: Qu, Chao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8ctg40lkkib2ice3413gi0j5lh